These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12168057)

  • 1. Analysis of microsatellite instability in acquired drug-resistance human tumor cell lines.
    Picard SF; Franco N; Sergent C; Chauffert B; Lizard-Nacol S
    Oncol Rep; 2002; 9(5):971-6. PubMed ID: 12168057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin.
    Lin X; Ramamurthi K; Mishima M; Kondo A; Christen RD; Howell SB
    Cancer Res; 2001 Feb; 61(4):1508-16. PubMed ID: 11245458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of geno- and cytotoxicity of methylnitrosourea on MMR-proficient and MMR-deficient human tumor cell lines].
    Tronov VA; Kramarenko II; Smirnova TD; Terekhov SM
    Tsitologiia; 2006; 48(1):19-27. PubMed ID: 16568831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repair.
    Kondo A; Safaei R; Mishima M; Niedner H; Lin X; Howell SB
    Cancer Res; 2001 Oct; 61(20):7603-7. PubMed ID: 11606400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells.
    Anthoney DA; McIlwrath AJ; Gallagher WM; Edlin AR; Brown R
    Cancer Res; 1996 Mar; 56(6):1374-81. PubMed ID: 8640828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of mismatch repair in the induction of chromosomal aberrations and sister chromatid exchanges in cells treated with different chemotherapeutic agents.
    Vernole P; Pepponi R; D'Atri S
    Cancer Chemother Pharmacol; 2003 Sep; 52(3):185-92. PubMed ID: 12827294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
    Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of DNA mismatch repair in drug resistance.
    Fink D; Aebi S; Howell SB
    Clin Cancer Res; 1998 Jan; 4(1):1-6. PubMed ID: 9516945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatin.
    Cenni B; Kim HK; Bubley GJ; Aebi S; Fink D; Teicher BA; Howell SB; Christen RD
    Br J Cancer; 1999 May; 80(5-6):699-704. PubMed ID: 10360646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the mismatch repair system and p53 in the clastogenicity and cytotoxicity induced by bleomycin.
    Vernole P; Tedeschi B; Tentori L; Levati L; Argentin G; Cicchetti R; Forini O; Graziani G; D'Atri S
    Mutat Res; 2006 Feb; 594(1-2):63-77. PubMed ID: 16139849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.
    Keshelava N; Seeger RC; Groshen S; Reynolds CP
    Cancer Res; 1998 Dec; 58(23):5396-405. PubMed ID: 9850071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA polymerase zeta accounts for the reduced cytotoxicity and enhanced mutagenicity of cisplatin in human colon carcinoma cells that have lost DNA mismatch repair.
    Lin X; Trang J; Okuda T; Howell SB
    Clin Cancer Res; 2006 Jan; 12(2):563-8. PubMed ID: 16428501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shaping of tumor and drug-resistant genomes by instability and selection.
    Snijders AM; Fridlyand J; Mans DA; Segraves R; Jain AN; Pinkel D; Albertson DG
    Oncogene; 2003 Jul; 22(28):4370-9. PubMed ID: 12853973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of homologous recombination DNA repair in alkylating agent-treated stem cell clones: a possible role in the aetiology of chemotherapy-induced leukaemia.
    Worrillow LJ; Allan JM
    Oncogene; 2006 Mar; 25(12):1709-20. PubMed ID: 16278672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
    Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
    Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of camptothecin on double-strand break repair by non-homologous end-joining in DNA mismatch repair-deficient human colorectal cancer cell lines.
    Jacob S; Miquel C; Sarasin A; Praz F
    Nucleic Acids Res; 2005; 33(1):106-13. PubMed ID: 15642697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancers.
    Hienonen T; Sammalkorpi H; Enholm S; Alhopuro P; Barber TD; Lehtonen R; Nupponen NN; Lehtonen H; Salovaara R; Mecklin JP; Järvinen H; Koistinen R; Arango D; Launonen V; Vogelstein B; Karhu A; Aaltonen LA
    Cancer Res; 2005 Jun; 65(11):4607-13. PubMed ID: 15930278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
    Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
    Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells.
    Vernole P; Muzi A; Volpi A; Dorio AS; Terrinoni A; Shah GM; Graziani G
    Mutat Res; 2009 May; 664(1-2):39-47. PubMed ID: 19428379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.